regulation is the sole category represented across all 1 tracked stories. Drugmakers (domestic and overseas) is most often covered alongside China, which appears in 1 of these 1 story. Drugmakers (domestic and overseas) appears in 1 tracked Healthcare story from August 3, 2026.
Recent coverage · Drugmakers (domestic and overseas)
1story
avg impact
0%positive
0%negative
100% neutral
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Drugmakers (domestic and overseas)
regulation is the sole category represented across all 1 tracked stories. Drugmakers (domestic and overseas) is most often covered alongside China, which appears in 1 of these 1 story. Drugmakers (domestic and overseas) appears in 1 tracked Healthcare story from August 3, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Drugmakers (domestic and overseas). Shared-story counts are live from our verified record — not editorial picks.
China’s 12th centralized drug procurement round selects 65 essential medicines, promising lower-cost access for patients at 45,000 medical institutions by late 2026. New quality rules tighten oversight, and the program now covers 555 drugs since 2018.
Drugmakers (domestic and overseas) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.